Megan Harper
In December 2025, the Singapore-based deeptech startup Galatek announced it has secured approximately $30 million in Series A funding to accelerate its global expansion across Europe, North America, and Southeast Asia.
The company is led by CEO David Tian. Galatek is positioning itself as a critical infrastructure partner at the intersection of two high-stakes sectors: life sciences and semiconductor advanced packaging.
Current industrial workflows in labs and chip factories suffer from a “data-action gap” where high-level research software is disconnected from physical robotics. Galatek addresses this with its Abio platform, an integrated system that unifies Laboratory Information Management (LIMS), Electronic Notebooks (ELN), and hardware automation. By embedding vision AI and motion control algorithms directly into the workflow, Galatek enables “Smart Labs” and advanced semiconductor processes—such as precision wafer dicing and optical inspection—to operate with machine-level reliability and cloud-agnostic scalability.
The fresh capital will be used to advance product development for its “Abio” suite, strengthen its global supply chain, and deepen R&D collaborations with academic hubs like the National University of Singapore.
Market Signal
- The “Cleanroom” Intelligence Moat: Galatek is building a unique category: AI for ultra-clean, high-precision environments. By serving both Bio-labs and Semiconductor lines, they are creating a cross-industry infrastructure that generic industrial AI cannot penetrate due to the extreme accuracy requirements (micron-level) and regulatory compliance standards.
- Hardware-Software Verticalization: Unlike software-only AI startups, Galatek’s Abio platform owns the entire stack—from the digital lab notebook to the robotic arm’s movement. This “Full-Stack” approach is essential for industries where the cost of a single error (a failed organoid culture or a broken wafer) can reach six figures.
- Asia’s Deeptech Dominance: Headquartered in Singapore with delivery centers in the US and Germany, Galatek exemplifies the “Global-First” strategy of Southeast Asian deeptech. It leverages regional semiconductor expertise to capture the global demand for sovereign, high-precision manufacturing infrastructure.
Key Details
- Company: Galatek
- Funding: $30M Series A
- Headquarters: Singapore
- CEO: David Tian
- Core Product: Abio (Scientific & Industrial Automation Platform)
- Use Case: Smart laboratories, advanced semiconductor packaging, and vision-driven inspection
